-
Mashup Score: 0Pfizer says three doses of its vaccine produce a strong response in the youngest children. - 2 year(s) ago
The preliminary results appeared to show that three doses of the vaccine worked better than two.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Pfizer CEO, Albert Bourla, said in nationally televised interview, it is necessary to fend off waning protection.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
It is necessary to fend off waning protection, said Pfizer CEO, Albert Bourla, said in nationally televised interview. https://t.co/Hmfbs8Jo9z #interview #ceo #pfizer #pfizervaccine https://t.co/XEtUjDqxVI
-
-
Mashup Score: 0
Pfizer CEO, Albert Bourla, said in nationally televised interview, it is necessary to fend off waning protection.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Pfizer CEO, Albert Bourla, said in nationally televised interview, it is necessary to fend off waning protection. https://t.co/Hmfbs90Zy9 #interview #ceo #pfizer #pfizervaccine https://t.co/LEx5mdHiC0
-
-
Mashup Score: 0BNT162b2 vaccination induces durable SARS-CoV-2 specific T cells with a stem cell memory phenotype - 3 year(s) ago
SARS-CoV-2 mRNA vaccination induces stem cell memory T cells specific for the virus that persist up to 6 months.
Source: Science ImmunologyCategories: Infectious Disease, Latest HeadlinesTweet-
Researchers led by Dr. Giovanna Borsellino (@gborsel) at @SantaLuciaIRCCS have shown that the #PfizerVaccine elicits an immunologically competent and long-lived #SARSCoV2-specific T cell population. https://t.co/a1nJgJ873u | @SciImmunology https://t.co/JuiXwNnvtT
-
-
Mashup Score: 0
US federal health agencies are recommending an additional shot for this diverse patient population, and here on some insights about vaccine efficacy and breakthrough infections in these groups.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Qatar has one of the highest #vaccination rates in the world, but the waning efficacy of the #Pfizervaccine is leading to breakthrough infections. #COVID19 #vaccinationupdate #PfizerBiontech https://t.co/329EFahFE2
-
-
Mashup Score: 11Pop-Up Covid Vaccination Clinic 8/13/21 - 3 year(s) ago
IMPORTANT: PLEASE SUBMIT AN INDIVIDUAL SIGN UP FOR EACH PATIENT RECEIVING A VACCINE. MULTIPLE PATIENTS CANNOT BE INCLUDED ON THE SAME SIGN UP. NUSD will be offering a Pop-Up Vaccination Clinic (Pfizer only) on Friday, August 13th from 3pm-5pm. Patients can receive their 1st or 2nd dose at this clinic. If receiving your 2nd dose, please make sure to bring the CDC vaccination card from your 1st…
Source: www.signupgenius.comCategories: Latest Headlines, PediatricsTweet-
RT @AngeliqueAshby: Vaccination opportunity today! Register here: https://t.co/kLzN4FSB66 Walk ups also welcome. #PfizerVaccine Approv…
-
-
Mashup Score: 17Two doses of the SARS-CoV-2 BNT162b2 vaccine enhances antibody responses to variants in individuals with prior SARS-CoV-2 infection - 3 year(s) ago
Understanding the impact of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to the coronavirus disease 2019 (COVID-19) pandemic. In particular, it is necessary to understand how prior infection plus vaccination can modulate immune responses against variants of concern. To address this, we sampled 20…
Source: Science Translational MedicineCategories: Future of Medicine, Latest HeadlinesTweet-
A new @ScienceTM study of healthcare workers vaccinated with the #PfizerVaccine shows that prior infection with #SARSCoV2 can boost antibody responses to variants of concern, suggesting boosters may help maintain immunity from #COVID19 vaccines. https://t.co/Juz4Dzt2VB https://t.co/OfwpGuMZQZ
-
-
Mashup Score: 102Two doses of the SARS-CoV-2 BNT162b2 vaccine enhances antibody responses to variants in individuals with prior SARS-CoV-2 infection - 3 year(s) ago
Understanding the impact of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to the coronavirus disease 2019 (COVID-19) pandemic. In particular, it is necessary to understand how prior infection plus vaccination can modulate immune responses against variants of concern. To address this, we sampled 20…
Source: Science Translational MedicineCategories: Future of Medicine, Latest HeadlinesTweet-
A new @ScienceTM study of healthcare workers vaccinated with the #PfizerVaccine shows that prior infection with #SARSCoV2 can boost antibody responses to variants of concern, suggesting boosters may help maintain immunity from #COVID19 vaccines. https://t.co/Juz4Dzt2VB https://t.co/MEnpo8IiTH
-
-
Mashup Score: 0
A report says the timetable for it is Labor Day or sooner.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking #FDA looking at potential full approval for #PfizerVaccine by Labor Day or sooner. #COVID19 https://t.co/HrjY9Et6Yu
-
-
Mashup Score: 0Behind the scenes of developing Pfizer’s Covid vaccine - 3 year(s) ago
BioNTech co-founder talks about developing the Covid vaccine with Pfizer — and experts answer questions from a global audience
Source: Elsevier ConnectCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The co-founder of @BioNTech_Group talks about developing the #CovidVaccine with Pfizer — and experts answer questions from a global audience: https://t.co/JXg23b5CYN #CovidVaccines #mRNAvaccine #PfizerVaccine
-
#Pfizer says three doses of its #PfizerVaccine produce a strong response in the youngest children. https://t.co/umJoiMn5JY @NYTimes